Filing Details

Accession Number:
0000950170-23-064799
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-17 16:05:32
Reporting Period:
2023-11-15
Accepted Time:
2023-11-17 16:05:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773383 Dynatrace Inc. DT () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1537211 Thoma Bravo Fund X, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1537212 Thoma Bravo Fund X-A, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1579904 Thoma Bravo Special Opportunities Fund I, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1606286 Thoma Bravo Fund Xi, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1606287 Thoma Bravo Fund Xi-A, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1606288 Thoma Bravo Executive Fund Xi, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1722232 Thoma Bravo Partners Xi, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1783009 Thoma Bravo Partners X, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1783011 Thoma Bravo Special Opportunities Fund I Aiv, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1813487 Thoma Bravo Ugp, Llc C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-15 10,000,000 $50.00 31,857,273 No 4 S Indirect See footnote
Common Stock Disposition 2023-11-15 2,576,137 $0.00 31,857,273 No 4 J Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 J Indirect See footnote
Footnotes
  1. After giving effect to the distribution reported on this statement, consists of 3,239,632 shares held directly by Thoma Bravo Fund X, L.P. ("TB Fund X"), 694,491 shares held directly by Thoma Bravo Fund X-A, L.P. ("TB Fund X-A"), 15,250,396 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 7,482,290 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 329,933 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund"), 273,513 shares held directly by Thoma Bravo Special Opportunities Fund I, L.P. ("TB SOF"), 2,010,881 shares held directly by Thoma Bravo Special Opportunities Fund I AIV, L.P. ("TB SOF AIV"), 545,546 shares held directly by Thoma Bravo Partners X, L.P. ("TB Partners X"), and 2,030,591 shares held directly by Thoma Bravo Partners XI, L.P. ("TB Partners XI").
  2. TB Partners X is the general partner of each of TB Fund X, TB Fund X-A, TB SOF and TB SOF AIV. TB Partners XI is the general partner of each of TB Fund XI, TB Fund XI-A and TB Exec Fund. Thoma Bravo UGP, LLC is the ultimate managing member of TB Partners X and TB Partners XI. By virtue of the relationships described in this footnote, Thoma Bravo UGP, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A, TB Exec Fund, TB Partners X and TB Partners XI. Each of TB Partners X, TB Partners XI and Thoma Bravo UGP, LLC disclaims beneficial ownership of the shares owned by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund except to the extent of its pecuniary interest therein.
  3. Represents a distribution of (i) 159,600 shares held directly by TB SOF AIV, 22,217 shares held directly by TB SOF, 309,847 shares held directly by TB Fund X and 53,882 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 25,609 shares held directly by TB Exec Fund, 1,450,201 shares held directly by TB Fund XI, and 554,781 shares held directly by TB Fund XI-A, in each case to TB Partners XI.